Comparison of UFR With QFR in Stable Coronary Artery Disease
Comparison of Flow Ratio Derived From Intravascular Ultrasound With Coronary Angiography in Stable Coronary Artery Disease: Correlation With Fractional Flow Reserve
1 other identifier
observational
250
1 country
1
Brief Summary
Quantitative flow reserve (QFR), derived from coronary angiography, has shown high accuracy in detecting significant lesions. Ultrasonic flow ratio (UFR), a new development from IVUS, integrates physiological estimation with intravascular imaging. Although both QFR and UFR are effective, there's no conclusive evidence favoring one over the other. The study aims to compare UFR and QFR's diagnostic performance against the conventional FFR standard in detecting significant coronary lesions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2018
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedFirst Submitted
Initial submission to the registry
January 15, 2024
CompletedFirst Posted
Study publicly available on registry
March 21, 2024
CompletedMarch 21, 2024
March 1, 2024
5.5 years
January 15, 2024
March 18, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Compare diagnostic performance of QFR with UFR
baseline
Secondary Outcomes (1)
Correlation and agreement between QFR and UFR
baseline
Interventions
Invasive CAG was conducted following standard clinical procedures, encompassing multiple projections of both the left and right coronary arteries. The FFR was precisely measured using either an intracoronary pressure wire (Pressure Wire X; Abbott Vascular, Santa Clara, USA) or a rapid-exchange pressure microcatheter (Insight Lifetech, Shanghai, China) during peak hyperemia. This state of maximal hyperemia was achieved through the intravenous infusion of adenosine triphosphate (ATP) at a concentration of 150 μg/kg/min, administered via the forearm vein. Upon completion of the FFR assessment, the pressure wire or microcatheter was carefully retracted to the tip of the guiding catheter for a routine drift check. IVUS imaging was meticulously conducted using the iLab™ IVUS system, coupled with a 40-MHz OptiCross IVUS catheter (Boston Scientific, Fremont, USA), at a steady pullback speed of 0.5 mm/s.
Eligibility Criteria
The participants included in the study had at least one target lesion demonstrating 30% to 90% diameter stenosis, as visually estimated from CAG.
You may qualify if:
- Patients who underwent both IVUS imaging and FFR measurement on the same artery
You may not qualify if:
- Inadequate quality of CAG or IVUS images for QFR or UFR calculation
- Left main or ostial right coronary artery lesion
- The use of balloon predilatation or stent placement prior to FFR measurement or IVUS imaging
- Incomplete IVUS pullback across the entire lesion segment
- The presence of a severe myocardial bridge (defined as ≥30% systolic diameter stenosis) in the examined vessel
- History of previous coronary artery bypass grafting,
- Left ventricular ejection fraction \<35%
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Zhongshan Hospital, Fudan University
Shanghai, 210000, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
January 15, 2024
First Posted
March 21, 2024
Study Start
July 1, 2018
Primary Completion
December 31, 2023
Study Completion
December 31, 2023
Last Updated
March 21, 2024
Record last verified: 2024-03